Psoriasis Clinical Trial

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Summary

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Men and women diagnosed with stable plaque psoriasis for 6 months or more. Stable psoriasis is defined as no morphology changes or significant flares of disease activity in the opinion of the investigator.
Deemed by the investigator to be a candidate for phototherapy or systemic therapy.
≥ 3% of Body Surface Area (BSA) involvement at the Screening Visit and Day 1
Dermatology Life Quality Index (DLQI) score > 5 at the Screening Visit and Day 1
Moderate-to-severe plaque psoriasis as defined by static Physician Global Assessment (s-PGA) ≥ 3 at the Screening Visit and Day 1

Exclusion Criteria:

Target Disease Exceptions:

Non-plaque psoriasis (that is, guttate, pustular, erythrodermic, palmoplantar only involvement or drug-induced psoriasis) at Screening Visit or Day 1

Other protocol-defined inclusion/exclusion criteria apply.

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

174

Study ID:

NCT05701995

Recruitment Status:

Recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 36 Locations for this study

See Locations Near You

Medical Dermatology Specialists
Phoenix Arizona, 85006, United States More Info
Lindsay Ackerman, Site 0006
Contact
602-354-5770
Center for Dermatology and Plastic Surgery/CCT Research
Scottsdale Arizona, 85260, United States More Info
Kenneth Steil, Site 0034
Contact
480-577-8189
Arkansas Research Trials, Inc.
North Little Rock Arkansas, 72117, United States More Info
Scott Dinehart, Site 0015
Contact
15018703299952
Bakersfield Dermatology Skin Cancer Med.Group
Bakersfield California, 93309, United States More Info
Jeffrey Crowley, Site 0004
Contact
661-327-3756
Integrative Skin Science and Research
Sacramento California, 95815, United States More Info
Raja Sivamani, Site 0009
Contact
510-847-6713
MedDerm Associates
San Diego California, 92103, United States More Info
Michelle Pelle, Site 0022
Contact
619-542-0013
SF Research Institute
San Francisco California, 94127, United States
Foxhall Research Center
Washington District of Columbia, 20016, United States More Info
Alison Ehrlich, Site 0024
Contact
202-695-1000
Florida Academic Centers Research and Education, LLC
Coral Gables Florida, 33134, United States More Info
Francisco Kerdel, Site 0016
Contact
305-324-2110
Riverchase Dermatology
Pembroke Pines Florida, 33028, United States More Info
Robert Snyder, Site 0011
Contact
954-435-5100
Atlanta Biomedical Clinical Research
Atlanta Georgia, 30331, United States More Info
Alia Sampson-Brown, Site 0037
Contact
678-515-3446
Gwinnett Clinical Research Center
Snellville Georgia, 30078, United States More Info
Jonathan Weiss, Site 0020
Contact
770-972-2241
Arlington Dermatology SC
Rolling Meadows Illinois, 60008, United States More Info
Michael Bukhalo, Site 0007
Contact
847-392-5440
NorthShore University Health System
Skokie Illinois, 60077, United States More Info
Stephanie Mehlis, Site 0025
Contact
847-663-8530
Springfield Clinic
Springfield Illinois, 62703, United States More Info
Jeave Reserva, Site 0036
Contact
1217528754124464
DelRicht Research
Baton Rouge Louisiana, 70809, United States More Info
Ira Thorla, Site 0003
Contact
225-412-0316
DermAssociates
Rockville Maryland, 20850, United States More Info
Benjamin Lockshin, Site 0018
Contact
301-355-3183
Oakland Hills Dermatology PC
Auburn Hills Michigan, 48326, United States More Info
Christofer Buatti, Site 0010
Contact
248-858-2255
Michigan Dermatology Institute - Waterford
Waterford Michigan, 48328, United States More Info
Cory Rubin, Site 0002
Contact
JDR Dermatology Research
Las Vegas Nevada, 89148, United States More Info
James Del Rosso, Site 0017
Contact
702-596-6137
Skin Cancer and Dermatology Institute
Reno Nevada, 89509, United States More Info
Michael Heaphy, Site 0035
Contact
775-336-3665
Sadick Research Group LLC
New York New York, 10011, United States More Info
Neil Sadick, Site 0032
Contact
212-772-7242
Markowitz Medical
New York New York, 10128, United States More Info
Orit Markowitz, Site 0013
Contact
212-828-3120
Skin Search of Rochester
Rochester New York, 14623, United States More Info
John Tu, Site 0001
Contact
585-697-1818
Bexley Dermatology Research
Bexley Ohio, 43209, United States More Info
Matthew Zirwas, Site 0005
Contact
614-725-5010
Apex Clinical Research Center
Mayfield Heights Ohio, 44124, United States More Info
Jorge Garcia-Zuazaga, Site 0012
Contact
14404404430440
DermDox Centers for Dermatology
Sugarloaf Pennsylvania, 18249, United States More Info
Stephen Schleicher, Site 0023
Contact
570-459-0029
Clinical Research Center of the Carolinas
Charleston South Carolina, 29407, United States More Info
Todd Schlesinger, Site 0019
Contact
843-556-8886
Studies in Dermatology, LLC
Cypress Texas, 77433, United States More Info
Lauren Campbell, Site 0029
Contact
346-818-5204
Jordan Valley Dermatology and Research Center
South Jordan Utah, 84095, United States More Info
Douglass Forsha, Site 0008
Contact
801-316-0266
Springville DermatologyCCT Research
Springville Utah, 84663, United States More Info
Michael Peterson, Site 0033
Contact
312-523-7408
Bellevue Dermatology Clinic
Bellevue Washington, 98004, United States More Info
Clive Liu, Site 0021
Contact
425-455-2275
Frontier Derm Partners
Mill Creek Washington, 98012, United States More Info
Eingun Song, Site 0031
Contact
425-275-4404
Premier Clinical Research LLC
Spokane Washington, 99202, United States More Info
William Werschler, Site 0014
Contact
509-343-3710
Dr. Samuel Sanchez P.S.C.
Caguas , 00727, Puerto Rico More Info
Samuel Sanchez-Rivera, Site 0040
Contact
(787) 746-3136
Grupo Dermatologico de Carolina
Carolina , 985, Puerto Rico More Info
Alma Cruz, Site 0038
Contact
7877691954

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

174

Study ID:

NCT05701995

Recruitment Status:

Recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.